Biogen Idec Inc $306.75

up +0.55


23/4/2014 05:20 PM  |  NASDAQ : BIIB  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get BIIB Trend Analysis - it has outperformed the S&P 500 by 22%

Partner Headlines

  1. Biogen EPS misses, guides up

    IBD
  2. Biogen Q1, Guidance Strong, But Stock Slips

    IBD
  3. Market Wrap For April 23: S&P 500 Ends Winning Streak, Apple Announces ...

    Benzinga
  4. Biogen Q1 Sales Beat Street, Guidance Strong

    IBD
  5. Earnings Scheduled For April 23, 2014

    Benzinga
  6. Ken Fisher's Top Increases of the First Quarter

    GuruFocus
  7. A Drill Can Help Identify Right Time To Sell Leaders

    IBD
  8. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  9. Johnson & Johnson: Why Top Funds Are Buying

    YCharts
  10. Biogen Idec Signs License Agreement With Amunix for XTENylated Factor VIII; ...

    Benzinga
  11. Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings

    IBD
  12. Stocks: Thin Gains; Yellen Coaxes Banks To Fortify

    IBD
  13. Biogen to Present Clinical Data from Neurology Portfolio at AAN Annual ...

    Benzinga
  14. IPO Frenzy Freezes As 4 New Issues Delayed

    IBD
  15. Stocks Hit Again; Nasdaq Ends Below 4000

    IBD
  16. Hemophilia drug draws plaudits

    IBD
  17. Market Wrap For April 10: Wednesday's Rally Completely Forgotten

    Benzinga
  18. Biotech IPOs Adamas, Cerulean Slump In Trading Debut

    IBD
  19. Software, Biotech, Solar Names Weigh on Nasdaq

    IBD
  20. Sellers Dictate Action As Growth Stocks Tumble Again

    IBD
  21. Stocks Fall Hard In Early Trade; Biotechs Take Heat Again

    IBD
  22. Stocks Mixed, Volume Mixed; HP, IBM, AT&T Rise

    IBD
  23. Nasdaq Up 1.7%; Bed, Bath & Beyond Sinks After Hours

    IBD
  24. Stocks Extend Gains; Trimble Navigation Finds Support

    IBD
  25. Alexion, Biogen Among Leading Big-Cap Biotechs

    IBD
  26. Don't Panic Over Recent Tech Turmoil

    FoxBusiness
  27. Stocks Rally, Stall, Turn Mixed; Consol Energy, U.S. Steel Jump

    IBD
  28. Biotechs Struggling To Find A Bottom

    Benzinga
  29. Biogen Idec May Have Seeds For Next-Gen MS Drugs

    IBD
  30. Stocks Weaken In Late Trade; Questcor Pares Gains

    IBD
  31. Major Averages Face More Selling, Biotechs Rally Back

    IBD
  32. IBD 50 Stocks Fade With Market; Some Trip Sell Rules

    IBD
  33. Stocks Fall Ahead Of Jobs Data; Palo Alto, Tableau Slide

    IBD
  34. Nasdaq Sheds 1% As China Growth Names, Biotechs Fall Hard

    IBD
  35. S&P 500 Edges Lower As Biotech Selling Weighs On Nasdaq

    IBD
  36. Nasdaq Leads Another Up Day; S&P 500 Hits All-Time High

    IBD
  37. Trial Results Lift Drug Sector

    IBD
  38. Stocks Hold Gains After Yellen Comments; Biotechs Bounce

    IBD
  39. Gilead Adds To Biotech Woes

    IBD
  40. Gains Fade Into Quiet Finish

    IBD
  41. Gilead Sovaldi Scrips Falter As Biotechs Keep Falling

    IBD
  42. Rebound Rally Losing More Steam; BitAuto Hangs Tough

    IBD
  43. Baxter Splitting In Effort To 'Unlock Trapped Value'

    IBD
  44. Market Wrap For March 27: Markets Lower Following Mixed Economic Data

    Benzinga
  45. Biotech ETFs Come Back Down To Earth

    Benzinga
  46. Morgan Stanley's Top Biotech Pick is Biogen

    Benzinga
  47. Baxter To Split Into Two Companies; Stock Jumps

    IBD
  48. BIOGEN IDEC

    IBD
  49. Top Industry Groups Take Big Hits In Market Sell-Off

    IBD
  50. Nasdaq Pierces 50-Day Line; Growth Stocks Fall Hard Again

    IBD
Trading Center